CClinicalTrials.gg
Sign In
CompletedNCT00237965Updated Oct 13, 2005

The Use of Mole Mapping Diagrams to Increase Skin Self Examination Accuracy

An interventional study of Mole Mapping Diagram in Melanoma, sponsored by Brown University. Completed. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2005-10-13.

Sponsored by Brown University · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to improve Skin Self-Examination accuracy by a simple cost effective intervention requiring participants to complete a mole-mapping diagram.

02

Conditions studied

  • Melanoma

Browse trials for

Keywords

  • Skin Self Examination
  • Mole Mapping Diagram
  • Melanoma
03

In context

Melanoma

3,006 studies on the registry are indexed under Melanoma; 520 are open to participants now.

Browse Melanoma studies →

Lead sponsor

Brown University is the lead sponsor of 282 studies on the registry; 42 are open to participants now.

Of its 25 completed or terminated interventional studies of FDA-regulated products, 18 (72%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Male and female subjects above age 18 of any ethnicity will be enrolled in this study.

Exclusion criteria

Exclusion Criteria:

  • Subjects will be excluded from the study if they have significant skin disease which would not allow manipulation of their photographs consistent with the rest of the subjects.
  • Since the study instructions are in English, Non-English speakers will be excluded.
  • Those with co-morbidity sufficiently severe to prevent them from being able to perform a SSE will be excluded.
  • In addition, those with cognitive impairment who are unable to give informed consent, or to understand the study instructions given to them, will be excluded.
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single

Interventions

  • BehavioralMole Mapping Diagram
06

Study locations

No study locations are listed for this record.

07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 13, 2005, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00237965
Lead sponsor
Brown University
First posted
Oct 13, 2005
Last update
Oct 13, 2005

Study contacts

Martin A Weinstock, MD, Ph.D
principal investigator · Veterans Affairs Medical Center Providence, RI
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2004. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Melanoma→

Other studies from this sponsor

Brown University

Start the discussion